MAX Surgical Specialty Management Secures Major Funding to Expand Services in the Northeast Region

MAX Surgical Specialty Management Secures Major Funding

MAX Surgical Specialty Management, widely recognized for its leadership in oral and maxillofacial surgery (OMS), has officially secured a significant boost in its operations through a newly obtained $77 million senior credit facility. This financing has been made available by Freeport Financial Partners, LLC, and is aimed at propelling the company's growth strategy in the Northeastern United States.

Accelerating Growth in the Northeast

According to Mark Censoprano, Co-CEO of MAX, the infusion of capital will strategically enhance the company's ability to form new partnerships with leading OMS practices throughout the region. Emphasizing community engagement, Censoprano stated, "Staying close to the communities we serve is at the heart of our partnership strategy. This capital allows us to expand strategically throughout the region, building relationships where they matter most.”

Strategic Partnerships

In line with this growth strategy, MAX has recently announced a notable partnership with Rothman and Kim Oral Maxillofacial Surgery (RKOMS), a highly regarded provider located in Philadelphia and Cinnaminson, New Jersey. RKOMS, helmed by experienced professionals Marc Rothman, DMD, and M. David Kim, DMD, boasts an established track record of delivering exceptional patient care over the past 25 years. This collaboration marks MAX’s second strategic alliance in Pennsylvania, following the successful integration of Oral and Maxillofacial Surgery of Westfield into their expanding network.

Under the expert guidance of Dr. Ronen Gold, this practice has gained acclaim for its commitment to clinical excellence and a patient-first philosophy. The incorporation of RKOMS further cements MAX's leadership in the OMS landscape across New Jersey, boosting its credibility and influence in the market.

Building an Elite Network of Professionals

Dr. Jason M. Auerbach, Founder and Co-CEO of MAX, commented on the development by highlighting that the company is committed to assembling a network of elite oral and maxillofacial surgeons dedicated to advancing excellence in patient care. He noted the impressive reputations that Drs. Rothman, Kim, and Gold have cultivated within their respective markets, crediting MAX's operational support and the newly acquired capital as key drivers in their forthcoming growth and continued innovation.

Since the beginning of 2024, MAX has increased its footprint by adding 14 practice locations and welcoming 17 surgeons into its network, expanding its presence across New Jersey, New York, Pennsylvania, Vermont, and Connecticut. This rapid growth trajectory has led to a near doubling of its overall headcount, now exceeding 300 personnel, underscoring the success of its market strategy and investment in clinical talent.

Confidence from Investors

Reflecting on the investment, Matt Gerdes, Managing Director of Freeport Financial Partners, expressed his confidence in MAX, stating, "This investment in MAX reflects deep confidence in the platform's outstanding performance, disciplined execution, and leadership team.” According to Gerdes, the company's strong fundamentals combined with a promising potential for long-term value creation make this funding a compelling opportunity.

MAX's strategic positioning relies on a concentrated network of OMS practices throughout the Northeast, which not only enhances regional insights and relationships but also provides contracting advantages that are critical in today’s competitive healthcare landscape.

About MAX Surgical Specialty Management

Founded in September 2022, MAX Surgical Specialty Management is dedicated to transforming the oral and maxillofacial surgery platform in the Northeast. As a surgeon-led management services organization, it is designed to prioritize both clinical and surgeon autonomy, ultimately aiming to advance the industry while ensuring the highest standards in patient care. By fostering collaboration among a curated network of top-tier surgical professionals, MAX empowers its partners to achieve their goals while maintaining their independence. The company is proud to be backed by notable investors including MedEquity Capital, RF Investment Partners, and Kian Capital, ensuring robust support for its strategic vision.

For more in-depth information about MAX and its initiatives, you can visit max-ssm.com.